PTCT Rule 144 notice: proposed sale of 55,000 shares on 10/03/2025
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
PTC Therapeutics (PTCT) filed a Form 144 notice for a proposed sale of 55,000 shares of common stock. The filing lists an aggregate market value of $3,632,946.95 for the shares and an approximate sale date of 10/03/2025. The designated broker is Fidelity Brokerage Services LLC, and the shares are listed on NASDAQ.
The shares were acquired via an option grant dated 01/04/2016, from the issuer, with payment noted as cash on 10/03/2025. The filing also reports 79,438,094 shares outstanding. This notice reflects an intention to sell under Rule 144 and does not itself execute a transaction.
Positive
- None.
Negative
- None.
FAQ
What did PTCT disclose in this Form 144?
A proposed sale of 55,000 shares of common stock with an aggregate market value of $3,632,946.95.
Which broker is listed for the PTCT Form 144 sale?
The filing names Fidelity Brokerage Services LLC as the broker.
Does this Form 144 mean the sale has occurred?
No. It is a notice of proposed sale under Rule 144, not a completed transaction.